ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

538 results

PCI optimisation in ACS patients

12 Dec 2020 – From GulfPCR-GIM 2020

Watch this session to learn through case examples how to optimise the treatment and results of ACS patients both at the short and long-term and to understand the importance of physiology assessment in ACS and the latest evidence from the field.

This session was originally presented during...

PCI optimisation in ACS patients

Tony Gershlick - A tribute from South Africa

24 Nov 2020

On behalf of the whole PCR Community, William Wijns and Jean Fajadet, Chairmen of PCR, extend their condolences upon the loss of Tony Gershlick. Read this tribute to an exceptional teacher and mentor in interventional cardiology by Farrel Hellig and David Kettles.

Author

Farrel Hellig

Author

David Kettles
Tony Gershlick

Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque

30 Nov 2020

Do you have any experience with NIRS technology? Do you think that use of 3rd generation DES would have shown better results than BVS? Read this review by S. Brugaletta

Reviewer

Salvatore Brugaletta
PCI for vulnerable coronary atherosclerotic plaque

STEMI and COVID-19: when two potential killers join up

11 Nov 2020

Is COVID responsible for myocardial injury (including STEMI) or is it an innocent bystander? View this case of a male patient, 70+ years with clear COVID symptoms for several days, presenting with chest pain starting about 3h before admission. Past history: permanent Afib on Eliquis.

Dr. Marko Noc

Author

Marko Noc
STEMI and COVID-19: when two potential killers join up

The EURO SHOCK Trial: Design, aims and objectives

19 Nov 2020

Randomised comparison of extra corporeal membrane oxygenation (ECMO) delivered after acute-PCI plus standard of care versus standard of care alone after acute PCI, in patients presenting with ACS and cardiogenic shock

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
The EURO SHOCK Trial: Design, aims and objectives

Association of intra-arrest transport vs continued on-scene resuscitation with survival to hospital discharge among patients with out-of-hospital cardiac arrest (OHCA)

04 Nov 2020

This multicentre time-dependent propensity score–matched cohort study was designed to evaluate the impact of intra-arrest transport as compared to continued on-scene resuscitationon survival to hospital discharge among patients experiencing out-of-hospital cardiac arrest.

Luigi Biasco

Reviewer

Luigi Biasco
Gregorio Tersalvi

Reviewer

Gregorio Tersalvi
Association of intra-arrest transport vs continued on-scene resuscitation with survival to hospital discharge among patients with out-of-hospital cardiac arrest

The impact of COVID-19 pandemic on interventional cardiologists in training

23 Oct 2020

In collaboration with EuroIntervention Journal

The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...

The impact of COVID-19 pandemic on interventional cardiologists in training

Arterial lactate in cardiogenic shock: Prognostic value of clearance versus single values

15 Oct 2020

This subanalysis of the IABP-SHOCK study shows how a negative trial, when properly conducted, can generate useful hypothesis-generating information with relevant clinical impact. Find out more!

Luigi Biasco

Reviewer

Luigi Biasco
Arterial lactate in cardiogenic shock: Prognostic value of clearance vs single values

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome

06 Oct 2020

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Prasugrel-based de-escalation of DAPT after PCI in patients with ACS

IREMMI: Outcomes of MitraClip in patients with acute mitral regurgitation in AMI with and without cardiogenic shock

17 Oct 2020

At TCT Connect 2020, Rodrigo Estevez-Loureiro presented the results of the IREMMI trial. Nicole Karam provides a summary of the key messages.

Author

Nicole Karam
Live from TCT Connect 2020: The IREMMI trial